Skip to main content
Premium Trial:

Request an Annual Quote

SQI Diagnostics Looks to Raise $3.7M in Private Placement

NEW YORK (GenomeWeb News) – SQI Diagnostics today announced a non-brokered private placement intended to raise C$3.76 million (US$3.72 million) in gross proceeds.

The Toronto-based microarray diagnostic firm said it plans to offer up to a little more than 5 million units at C$.75 per unit as part of the placement. Each unit will consist of one common share and one common share purchase warrant. Each warrant will entitle the holder to buy one common share at C$1.10 for up to two years after the date of issuance.

The private placement is anticipated to close on or about May 1, SQI said.

SQI plans to use net proceeds from the placement for product development and commercialization, as well as sales and marketing, and general working capital.

The cash-strapped firm is in the midst of a turnaround effort. In November it created a special committee to review strategic alternatives, including a possible merger or sale. In its recent first quarter results it reported C$3,000 in revenues, which followed a 2012 fourth quarter in which it reported no revenues.

As of Dec. 31, 2012, the company had C$2.0 million in cash and cash equivalents.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.